CD133+ Cell Therapy for Refractory Coronary Heart Disease

Clinical trial NCT01049867 · UNKNOWN

Trial details

NCT number: NCT01049867
Sponsor: Hospital y Clinica OCA, S.A. de C.V.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2009-12-01
Primary completion: 2010-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.